APG IV system

B. Braun Launches Introcan Safety® 2 IV Catheter with Multi-Access Blood Control Designed to Protect Clinicians Every Time the Hub is Accessed

Retrieved on: 
Wednesday, October 11, 2023
Workload, Risk, APG IV system, IV, Vascular access, Patient, Injury, Medical device, Chief security officer, Marketing

The Introcan Safety 2 IV Catheter is the latest development from B. Braun in a long line of passive needlestick prevention catheters.

Key Points: 
  • The Introcan Safety 2 IV Catheter is the latest development from B. Braun in a long line of passive needlestick prevention catheters.
  • In addition to automatic needlestick protection, clinicians are protected from blood exposure by a blood control feature every time the hub is accessed1 – reducing the risk of bloodborne pathogen exposure throughout the IV process.
  • In addition to needlestick injuries, mucocutaneous blood exposure due to blood spillage from the catheter hub is also a concern.
  • "The newly launched Introcan Safety 2 IV Catheter with Multi-Access Blood Control provides clinicians with another option when choosing the right device for their patients.

B. Braun Launches Introcan Safety® 2 IV Catheter with One-time Blood Control Designed to Make IV Access Safer for Clinicians

Retrieved on: 
Tuesday, July 12, 2022
Blood, Safety, IV, Multimedia, Injury, Nursing, Centers for Disease Control and Prevention, Company, Infection, Infection Control & Hospital Epidemiology, Risk, Hepatitis B, Patient, Hubli railway division, Center, PMID, Needlestick injury, RN, DOI, HIV, APG IV system, Luer, B. Braun, Degenerative disease, Workplace safety in healthcare settings, MS, CNS, Pain management, Dialysis, Doctor of Philosophy, CDC, Medical device, Hospital, Television, Pharmaceutical industry, Marketing

The Introcan Safety 2 IV Catheter is the latest development from B. Braun for making IV access safer for the clinician by reducing the risk of needlestick injuries and their exposure to blood.

Key Points: 
  • The Introcan Safety 2 IV Catheter is the latest development from B. Braun for making IV access safer for the clinician by reducing the risk of needlestick injuries and their exposure to blood.
  • [3] With Introcan Safety 2, clinicians are protected by a truly automatic passive safety device.
  • Not only are healthcare workers concerned about needlestick injuries, but also mucocutaneous blood exposure when starting an IV.
  • In fact, most nurses reported blood exposure as a concern for their own safety, as well as for their patients' safety.

B. Braun Launches CARESAFE™ IV Administration Sets With Optional AirStop

Retrieved on: 
Tuesday, September 21, 2021
Adoption, EDC, Centers for Medicare & Medicaid Services, Dioxin, Running, Phthalate, Pain management, Polyvinyl chloride, Vascular access, B. Braun, Medicare, American Medical Association, Patient, CMS, PVC, Atmosphere, Physician, Public health insurance option, Dialysis, Company, Hospital, Environment, Center, Risk, DEHP, Incineration, Male, APG IV system, United States National Library of Medicine, Pregnancy, Safety, Diagnosis, Multimedia, Medical device, Pharmaceutical industry, Thermoplastic

BETHLEHEM, Pa., Sept. 21, 2021 /PRNewswire/ --B. Braun Medical Inc. (B. Braun), a leader in infusion therapy and pain management, announced today the launch of its new CARESAFE IV Administration Sets with Optional AirStop component.

Key Points: 
  • BETHLEHEM, Pa., Sept. 21, 2021 /PRNewswire/ --B. Braun Medical Inc. (B. Braun), a leader in infusion therapy and pain management, announced today the launch of its new CARESAFE IV Administration Sets with Optional AirStop component.
  • CARESAFE IV Sets are the first robust portfolio of IV administration sets in the US market that are not made with polyvinyl chloride (PVC) and diethylhexyl phthalate (DEHP).
  • [4]
    In addition to reducing patient exposure to toxic substances, CARESAFE IV Sets with Optional AirStop component also help to protect patients from the risks associated with air infusion and helps prevent the line from running dry.
  • B. Braun Medical is headquartered in Bethlehem, Pennsylvania and is part of the B. Braun Group of Companies in the U.S., which includes B. Braun Interventional Systems, Aesculapand CAPS.